Understanding the Pakistan Budgeting Process: Basics and Key Insights
VigiFlow Introduction and Data Entry
1. VigiFlow –
Introduction and data
entry
Somnath Mondal
Technical Associate (PvPI)
STM-AMC
Dept. of Clinical & Experimental Pharmacology
Kolkata, India
June,14, 2013
2. Agenda
• Module I
–VigiBase – recapture
–VigiFlow
• General information and background
• Data entry
• Hands on…
• Module II
–VigiFlow – advanced concepts
• Advanced report handling
• Search and Statistics Somnath Mondal, STM-AMC Kolkata, India
3. What is VigiFlow?
A web based report management tool that
simplifies report management.
Complete ICSR Management System
ICSR (Individual Case Safety Report) –
A synonym for ADR report.
VigiFlow can be used by any authority or company as
a complete database for report management and
storage.
4. Complete ICSR Management System
–Data entry
–Assessment
–Storage
–Retreival (e.g. for follow-ups)
–Communication with other
parties
• It is web-based
• It is E2B compatible
Somnath Mondal, STM-AMC Kolkata, India
5. VigiFlow is not primarily a tool for
reporting to the UMC, but reports can
easily be sent through the system.
Somnath Mondal, STM-AMC Kolkata, India
6. Advantages:
General Aspects:
• Less delay in ADR reporting
– Sending a report is as fast as a mouse click
• Improved report quality
– Error checks and lexicons
– Help texts
– Mandatory fields
• (Predefined values in drop-down boxes)
• Outputs in several formats
– E2B, PDF, Excel
All factors that increase the report quality.
Somnath Mondal, STM-AMC Kolkata, India
7. Technical:
• Internationally recognised standards
– E2B report format
– WHO-ART and ICD or MedDRA
– WHO Drug Dictionary
• One server installation – maintained in Uppsala
– No local installation needed
– Immediate access to new versions of both
VigiFlow and terminologies/dictionaries
• Sharing of costs and ideas
– Development and maintenance
8. History
• 2001 – Swissmedic needed a new
pharmacovigilance system
– Support for primary notifier reporting
– 7 regional centres
– 4 languages
• A project was started – “ADR Pilot”:
– Version 0.1 – Summer 2003
– Version 1 – Autumn 2003
• E2B compatible version complying with international
standards
• With this version the first report was entered – by
Alex in Ghana
Somnath Mondal, STM-AMC Kolkata, India
9. Success Story: Swissmedic usage
• As mentioned Swissmedic has been using
VigiFlow for all their report management
since summer 2004.
– They have connected 7 regional centres,
including one specialized centre
– There is no more paper based reporting from
physicians directly to Swissmedic
• But companies are still sending reports on paper…
– They are today managing twice the amount of
reports compared to 2004 without increase in
staff
Somnath Mondal, STM-AMC Kolkata, India
10. VigiFlow
NC
NC
NC
Company
RC
RC
RC
RC
Flexibility of VigiFlow
Example 1 Example 3
Example 2
NCRC
Two strong centres in a country,
on set up as NC, one as RC.
Both the RC and the NC enters
and assesses their own reports.
The RC sends its reports to the
NC for committment into the
database of finialized reports.
NC
One NC (regional PV centres not
connected to VigiFlow
Only the National PV Centre is
connected to VigiFlow. All
reports are entered and
assessed by NC personnel.
(Not necessarily at the same
location.)
VigiFlow
VigiFlow
NC
RC
RC
RC
A strong NC with several RC
sharing the work of data entry.
The RCs enter the primary data
and sends the report to the NC.
The NC performs all
assessments and supports the
RCs in their work.
VigiFlow
Example 4
Companies with a need for ICSR
management can also use
VigiFlow.
CompanyVigiFlow
Magnus Wallberg, UMC
PvPI
11. Magnus Wallberg, UMC
Flow of reports in VigiFlow
Report
repository
Regulatory Authority
Regional Centre 1 Regional Centre 2
External
organizations E2B
(XML)
PDF
WHO
database -
VigiBaseE2B
(XML)
12. Magnus Wallberg, UMC
Pros and cons with VigiFlow
Pros
• Combination of structured and
free-text fields to encourage
complete data entry
• Integrated dictionaries and
terminologies ensures correct
coding
• Easy communication between
national and regional centres
• No need for local server upkeep
and back-ups
• Seamless transmission of
reports to WHO/UMC
Cons
• Server (with national data) in
another country might be
against national regulations
• Needs Internet access - at
least 0.5 Mbit/s for a good
experience
• Not 100% adaptable to local
ideas of how it “should work”
13. Magnus Wallberg, UMC
Terminologies used
• Terminology for coding reactions and indications
– WHO-ART / ICD
• Easy reporting and analysis
• Dictionary for coding drugs
– WHO Drug Dictionary
• Products from many countries as well as herbal products
15. Main parts
Report handling search and statistics exit
new report Send report list reports
Somnath Mondal, STM-AMC Kolkata, India
16.
17. Main parts: report handling
With this button you
create a new report
This button lists all
reports that are “under
assessment”
Somnath Mondal, STM-AMC Kolkata, India
18. Create a new report
Click this button to
create a new report
Standard case:
– A normal report with one patient taking a
drug and suffering from an ADR
Parent-child case:
– A report where a parent has taken a
medicine and the child is suffering from the
ADR
Somnath Mondal, STM-AMC Kolkata, India
19. Sections of the report input module
0. Report Information
1.Patient
2.Tests and procedures
3. Relevant Medical Histories
4.Past drug therapy
5.Reactions
6. Drugs
7. Assessment
8. Overview
9. Save
A. Print Report
0. Report Information
1.Patient
5.Reactions
6. Drugs
Somnath Mondal, STM-AMC Kolkata, India
Mandatory
20. General report information
• The first section of the report
• Collects information about
–General report data
–Sender of the report
–Primary source(s)
Somnath Mondal, STM-AMC Kolkata, India
21. General report data
Date received at Regional Center
dd mm ccyy
Date received at National Center
Report Title
Type of Report
Spontaneous
Study
Literature
Seriousness criteria
Country of occurrence
Somnath Mondal, STM-AMC Kolkata, India
22. Warning
Mandatory field
Tab. Metronidazole- Pancreatitis
This text will appear in
the report listing and
enable you to identify
your report , Fluoxetine-
Serotinin Syndrome or
Suppose
Serious
If case is serious, reason
for seriousness must be
given
Reason for Seriousness
All the criteria apply as
the case as a whole
and should not be
confused outcome (s) of
individual reaction (s)/
event (s)
Medically confirmed if
not initially from health
professional.
Only to be completed if
the primary reporter
was a lawyer,
consumer, or other
non-health
professional.
Somnath Mondal, STM-AMC Kolkata, India
26. General report information – sender details
• Information about the organization sending the report to
– Type of organization (Sender)
Pharmaceutical Company
Regional Pharmacovigilance Center
Health professional
Regulatory Authority
other
Regional Pharmacovigilance Center
– Name of sender and senders report number to be entered in admin
chapter
Somnath Mondal, STM-AMC Kolkata, India
27. • World wide unique number
– If you are the first receiver of the report this should be left blank. It will be
automatically filled with your report number.
– If you are not the first receiver, fill in the report number of the original sender
of the case
If the report has no worldwide
unique report number both the
fields should left empty. The
worldwide unique number then be
automatically assigned when a
report Id is generated.
This number will be remain
unchanged in all subsequent
transmissions.
If the report has worldwide
unique number, enter as either
authority report number or
company report number. This
number should remain unchanged
for subsequent transmission.
Somnath Mondal, STM-AMC Kolkata, India
29. General report information – primary source(s)
• Information about primary source
– Name and details of for example physician
– Literature reference
• To be filled in if a literature case
– Information about study details
• To be filled in if report from study
• The entire section is repeatable if there
are more than one primary source
• Possibility to save a reporter for later
re-use
Somnath Mondal, STM-AMC Kolkata, India
30. Somnath Mondal, STM-AMC Kolkata, India
Patient information
• Birth date, age or age group
• Initials
• Weight
• Height
• Sex
• Information on patient death
– Death date
– Death cause
– Autopsy information
31. This filed will be calculated
automatically if age of onset is
present.
The age group definitions used in
this application are
Neonate <= 1 month
infant <= 4 years
child <= 11 years
adolescent <=16 years
adult <= 69 years
elderly > 69 years
Onset age
This filed will be automatically
be calculated from „onset date
of reaction‟ and „date of birth‟
if both those dates are
completely entered & differ.
If „onset date of reaction‟ and
„date of birth‟ is identical or
incomplete, an onset date may
be entered.
Populate “unknown” if the
initial of the initials of
the patient is unknown.
(New amendment in 4.3
version of vigiflow)
Verify content Move to next
section
decade
Year
month
week
day
hour
Search for ICD-10 term
Somnath Mondal, STM-AMC Kolkata, India
32. Tests and procedures
• Allows for entry of test data
• Free text field
• Structured information
– The preferred option
– Test type entered as free text or by selection
from a drop down.
In appearance the test sections differs
somewhat from the rest of the tool since
there has been a wish to always see all
information for comparison reasons.
33. Free text entry
Add another “coded” test
Add test type as free text
or from drop down
(Only MedDRA term if MedDRA is
used as terminology)
Add another test result,
more than one can be
added at the same time
Copy dates if several tests
have been done at the
same date(s)
PassiveActive
34. Relevant medical history
• In this section medical history that might
be of importance is recorded
• Free text field
• Structured information
– Medical history term (ICD-10)
– Start and stop date
– Comment
35. Free text entry
3 medical history entries
added
Active entry
Details about
active entry
36. Past drug therapy
• In the past drug therapy section
information about previous
medications is recorded
–Drug name
–Indication (if available)
–Reaction (if applicable)
37. 2 past drug therapies
entered
Name of drug
(free text)
Indication (coded
with term lookup)Reaction (coded
with term lookup)
38. Free text entry
3 medical history entries
added
Details about
active entry
41. List of reactions
5 reactions added
Use the up arrow to move
the most important
reaction to the top
42. Reaction entry
Use the reaction lookup
tool to add the correct
term (described later)
Enter a new term only if
you could not find an
appropriate term in the
term lookup tool
43. Comments provided from
primary source (in free
text)
Coded reactions
The reaction in bold is the
“active” reaction below
Details about “active”
reaction
Relatedness assessment –
entered for each
drug/reaction combination
This field should be used to
include the primary reporter‟s
comments on diagnosis Causality
assessment or other issues
considering relevant.
Error
Maximum 500 characters
This field should reflect the
wording about the event as
received from the primarimary
reporter. (Original text unless to
avoid misunderstandings.)
Error
Maximum 200 characters
44. Drugs
• List of coded drugs
• Details about each individual drug
• Causality assessment
45. List of drugs
Use the up arrow to move
the most important drug to
the top
Add one more drug to the
report
3 suspected and 1
concomitant drug added
47. Coded drugs
The drug in bold is the
“active” drug below
Details about “active” drug
Relatedness assessment –
entered for each
drug/reaction combination
48. Drug reaction relatedness (Relatedness
assessment)
• Information on the relatedness of the
drugs and reactions coded on a report
– Relatedness information
• In VigiFlow – WHO Causality
– Information on recurrence
• Information entered in a “simple” matrix
Remove a relatedness with
the trash if NO relatedness
at all
49.
50. Assessment
• A number of “mainly” free text
fields
–Case narrative
–Sender’s comments
• Your comments
–Sender’s diagnosis
• Coded in ICD10 or MedDRA with the term lookup tool
–References
• Any references to other sources, like literature
51. Overview
• Shows a summary of the report
– All filled in fields
– All fields with errors or warnings
– Only to be used for a quick overview not
“print or read friendly”!
If you are about to finalize/commit a
report and it is reporting that it has
errors… this is the place where to go!
52.
53. Reaction lookup tool
• The reaction lookup tool has been rebuilt
in version 4.1 and further of VigiFlow.
New features are:
– The lookup is done without leaving the page
where the term shall be added
– The entire search tree is displayed in the
result
– Searches can be done with
• Begins with, equals and contains
– Searches can be done on specific levels
– Result tree can be expanded
55. Drug lookup tool
• With version 4.1 of VigiFlow one of the
major changes is the tool to pick drugs
from WHO-DD
• The aim is to:
– Make it easier to find the appropriate drug
and drug level
– Make it more difficult to suggest new
drugs!
56. Enter a new drug only if
you could not find an
appropriate drug in the
drug lookup tool
Select appropriate level
depending on available
information on report and
details available in WHO-
DD.
57. Comment on report entry
• VigiFlow contain a large number of data
fields, filling them all in may be very time
consuming
But…
• There are only 5 mandatory fields
–Header, initials (recently modified), Age
at the onset of ADR, drug, reaction
and onset date (Year)
On the other hand…
• More data will improve the overall quality and simplify the
causality assessment
58. VigiFlow – hands on
• Form groups of three or four
• One in the group must be a ”experienced” VigiFlow
user
– But – someone else should do the hands on!
• Create one ”made up” report with your ”group
name” in the report header and a small amount of
data
– Add at least two reaction
• Save and committ the report
– Write down the report number
• Search for the report in the search and statistics
tool and export the result set on excel format
59. Vigiflow Without Mouse
Access Keys to facilitate switching between
different pages without pressing mouse.
To switch to a specific pages the access keys
are Alt + [keys]
After opening the report handling page if we
want to go directly to drug entry page.. Alt +
[6] { Because in the left page menu particular
section denoted by a specific number or [Letter].
60. The access keys for buttom Entry
Alt+[c] and Alt+[n]
Variability based on Web Browser:
For Internet Explore: Alt+[1]+ Enter
For Mozilla Fire Fox: Shift + Alt+ [1]
Pressing back function in the secure web
browser is generally discouraged.